Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade
about
sameAs
The caveolin proteinsCaveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicin-induced apoptosisCardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioningCaveolinopathies: from the biology of caveolin-3 to human diseasesCharacterization of the molecular architecture of human caveolin-3 and interaction with the skeletal muscle ryanodine receptorCardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signalingKeeping Wnt signalosome in check by vesicular trafficNitric oxide synthases in heart failurePI3Ks maintain the structural integrity of T-tubules in cardiac myocytesPTRF/Cavin-1 Deficiency Causes Cardiac Dysfunction Accompanied by Cardiomyocyte Hypertrophy and Cardiac FibrosisCurrent understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas diseaseSubstrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts17 beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female ratsLocalization of Kv1.5 channels in rat and canine myocyte sarcolemmaMuscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formationCaveolin-1 modulates cardiac gap junction homeostasis and arrhythmogenecity by regulating cSrc tyrosine kinase.The coiled-coil domain of MURC/cavin-4 is involved in membrane trafficking of caveolin-3 in cardiomyocytes.MURC/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by α1-adrenergic receptors.The interaction of nucleoside diphosphate kinase B with Gbetagamma dimers controls heterotrimeric G protein function.Gene expression profile of rat left ventricles reveals persisting changes following chronic mild exercise protocol: implications for cardioprotection.Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy.Maternal nutrient restriction alters gene expression in the ovine fetal heart.Caveolin-3 associates with and affects the function of hyperpolarization-activated cyclic nucleotide-gated channel 4Therapeutic targeting of signaling pathways in muscular dystrophy.Caveolae, ion channels and cardiac arrhythmias.Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.Targeting of voltage-gated calcium channel α2δ-1 subunit to lipid rafts is independent from a GPI-anchoring motif.Identification and functional analysis of a new putative caveolin-3 variant found in a patient with sudden unexplained deathSignaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection.RNAi-based gene therapy for dominant Limb Girdle Muscular Dystrophies.Caveolae create local signalling domains through their distinct protein content, lipid profile and morphologyDefining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins.Caveolin contributes to the modulation of basal and β-adrenoceptor stimulated function of the adult rat ventricular myocyte by simvastatin: a novel pleiotropic effectPathway reporter genes define molecular phenotypes of human cellsActivation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy.Ultrasound-mediated stimulation of microbubbles after acute myocardial infarction and reperfusion ameliorates left-ventricular remodelling in mice via improvement of borderzone vascularization.The real estate of cardiac signaling: location, location, locationPalmitate diet-induced loss of cardiac caveolin-3: a novel mechanism for lipid-induced contractile dysfunction.Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.Cavin1; a regulator of lung function and macrophage phenotype.
P2860
Q21194854-55A1E2CE-5245-42A2-8F55-3B6D25BBCE82Q24299583-506D8F71-49F7-454B-B845-947E873C840AQ24336120-C8529A98-E926-48A8-9F45-D406BB7296E3Q24599074-8F7C14F8-B599-4AA7-90FB-53B3730A0DE9Q24608212-AFF08D59-450B-4838-B5E9-98037F3C09F1Q24629099-79D38F79-5703-49E1-8091-EFC145DC910CQ26822956-D2971A10-12FC-470C-A708-D4ACF915567BQ26830146-BA2F51BB-62ED-4C8A-B566-F7349B72AD48Q27321455-E544E3EE-65F4-4D10-9E29-90DD9897B472Q27322991-5D1CE7AD-8897-4B42-BB32-126F4EA1BEFBQ28391025-845FBFFF-DE9F-4A30-8A00-0E77EF6F8287Q28506400-9F6E5736-0DDD-4AD3-A99A-DE784EB78816Q28577156-B9529B60-CD11-4F53-9C6C-D3F8D562EC09Q28583447-C288D4E2-C4A6-48D1-9255-89673812E3C5Q28593015-87F18C6D-0678-4BC6-A9D1-5CDFAFE390CBQ29347261-F60566BA-2662-4F77-A722-8A548A3408C1Q30090158-FD0AA78C-1C6C-4309-ABAD-581B2DBDD234Q30090168-88E5DE56-80B4-42EA-AAFD-6C6674A507E4Q30490573-68C09D17-DC72-4753-85BE-470B194E1626Q30495607-8C40EFCA-25C2-4040-AC0C-EAE17C7F9F9DQ30498939-4F603CFE-A5D6-412F-B106-484CB17E47F3Q30831154-085C6E6B-DD32-4EB6-9819-C15C913C77FCQ33578159-1BB30707-75FE-4FC6-8367-AA17998BD433Q33707964-1F99C5CF-88F8-45F3-A804-8EC37D2B3D60Q33720799-C62A0D4A-16C1-4CED-9022-8569FD3F4786Q33814419-91ACCDAA-F5D1-4564-A2AB-A29F8395D568Q33939598-81A35D81-8816-4389-A81C-1AA6577B6ABFQ33943558-9DE7D512-60AB-4A79-A5B0-8E09BD4EEFA7Q33993790-06938A38-EB94-4C2A-A20C-493EB86C5371Q33996884-406826DA-ACD3-465D-9427-FAF911918DC6Q33998121-51D8B502-1274-485E-99F6-C5A2B8376C7DQ34095165-A1FB6F77-29E9-46A8-AD8F-86F62858FC56Q34166022-6337BD62-5092-4693-9F7F-09483593AEF2Q34473230-B5304DA0-8A85-4BAC-B2C9-549562C4261FQ34580311-BC689A0A-1C87-4ED4-9DF8-D5D489F3A1E2Q34599586-82591443-7601-4CFD-858A-C903636AD9EDQ34650496-916EDBAB-5634-4CB8-96C1-D66CC48A3788Q34667984-E6CF2DE9-C87E-483B-AE50-7358E7A3AFCDQ34686759-04FCBB97-9EBE-4E4C-99E9-7B58D6592CC8Q34698258-4B1BD62A-1D66-46EB-BAED-CCBF82A3CD0C
P2860
Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Caveolin-3 knock-out mice deve ...... ion of the p42/44 MAPK cascade
@ast
Caveolin-3 knock-out mice deve ...... ion of the p42/44 MAPK cascade
@en
Caveolin-3 knock-out mice deve ...... ion of the p42/44 MAPK cascade
@nl
type
label
Caveolin-3 knock-out mice deve ...... ion of the p42/44 MAPK cascade
@ast
Caveolin-3 knock-out mice deve ...... ion of the p42/44 MAPK cascade
@en
Caveolin-3 knock-out mice deve ...... ion of the p42/44 MAPK cascade
@nl
prefLabel
Caveolin-3 knock-out mice deve ...... ion of the p42/44 MAPK cascade
@ast
Caveolin-3 knock-out mice deve ...... ion of the p42/44 MAPK cascade
@en
Caveolin-3 knock-out mice deve ...... ion of the p42/44 MAPK cascade
@nl
P2093
P921
P3181
P356
P1476
Caveolin-3 knock-out mice deve ...... ion of the p42/44 MAPK cascade
@en
P2093
Alex W Cohen
Baiyu Tang
David S Park
George J Christ
Jamshid Shirani
Linda A Jelicks
Madhulika Chandra
Michelle W-C Cheung
Richard N Kitsis
Scott E Woodman
P304
P3181
P356
10.1074/JBC.M205511200
P407
P577
2002-10-11T00:00:00Z